MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/biomedicines14092034

Медицинская библиотека · Biomedicines · 2026

Non-Selective β-Blocker Use and Portal Vein Thrombosis in Cirrhosis: An Updated Systematic Review and Meta-Analysis.

Lai Sanchuan, Wei Wei, Su Tingting

СтатьяОбзорПеревод в очереди

Аннотация

Background/

Objectives

The association between non-selective β-blocker (NSBB) use and portal vein thrombosis (PVT) in patients with cirrhosis remains controversial. Prior meta-analyses had notable methodological limitations and may have overestimated this relationship. This updated systematic review and meta-analysis aimed to comprehensively evaluate the association between NSBB therapy and PVT risk in cirrhotic populations.

Methods

We systematically searched PubMed, Web of Science, the Cochrane Library, and EMBASE up to 24 January 2026. Observational clinical studies comparing PVT incidence between cirrhotic patients receiving NSBBs and those not receiving NSBB treatment were included. The Newcastle-Ottawa Scale (NOS) was used for methodological quality assessment. Pooled odds ratios (ORs) and hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated separately using random-effects models. Subgroup, sensitivity, and publication bias analyses were performed to explore heterogeneity and verify result robustness.

Results

Eighteen observational studies enrolling 8104 cirrhotic patients were finally included. For binary PVT endpoints from 12 studies, NSBB use was significantly associated with elevated PVT risk (pooled OR = 1.89, 95% CI 1.29-2.78), with moderate-to-high between-study heterogeneity (I2 = 67.8%). For longitudinal incident PVT evaluated by HRs in 6 cohort studies, the overall pooled association did not reach statistical significance (HR = 1.61, 95% CI 0.99-2.63). Subgroup analyses demonstrated that the effect size was further attenuated after multivariable adjustment.

Conclusions

Observational evidence reveals a correlation between NSBB exposure and higher PVT prevalence in cirrhotic patients. However, adjusted longitudinal data fail to confirm that NSBB therapy independently increases the risk of de novo PVT. Large-scale, well-adjusted prospective cohort studies are needed to verify the relationship between NSBB administration and incident PVT.

Для цитирования: Lai Sanchuan, Wei Wei, Su Tingting. Non-Selective β-Blocker Use and Portal Vein Thrombosis in Cirrhosis: An Updated Systematic Review and Meta-Analysis.. Biomedicines. 2026. DOI: 10.3390/biomedicines14092034.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.